SDF-1/CXCR4 Signaling Maintains Stemness Signature in Mouse Neural Stem/Progenitor Cells
Overview
Authors
Affiliations
SDF-1 and its primary receptor, CXCR4, are highly expressed in the embryonic central nervous system (CNS) and play a crucial role in brain architecture. Loss of SDF-1/CXCR4 signaling causes abnormal development of neural stem/progenitor cells (NSCs/NPCs) in the cerebellum, hippocampus, and cortex. However, the mechanism of SDF-1/CXCR4 axis in NSCs/NPCs regulation remains unknown. In this study, we found that elimination of SDF-1/CXCR4 transduction caused NSCs/NPCs to lose their stemness characteristics and to encounter neurogenic differentiation. Moreover, Notch and RE1 silencing transcription factor (REST) both play an essential role in NSCs/NPCs maintenance and neuronal differentiation and were dramatically downregulated following SDF-1/CXCR4 cascade inhibition. Finally, we demonstrated that the expression of achaete-scute homolog 1 (Ascl1), a proneural gene, and p27, an antiproliferative gene, were significantly increased after genetic elimination of SDF-1 alleles. Our results support that the loss of functional SDF-1/CXCR4 signaling pathway in NSCs/NPCs induces exit of cell cycle and promotes premature neural differentiation.
Bayat Tork M, Saberifar M, Joneidi Yekta H, Hajinejad M, Ravandi H, Gorji A Sci Rep. 2025; 15(1):5811.
PMID: 39962142 PMC: 11832925. DOI: 10.1038/s41598-025-85698-5.
The Role of Hypoxia and Cancer Stem Cells in Development of Glioblastoma.
Shi T, Zhu J, Zhang X, Mao X Cancers (Basel). 2023; 15(9).
PMID: 37174078 PMC: 10177528. DOI: 10.3390/cancers15092613.
Inhibition of PIM Kinases Promotes Neuroblastoma Cell Differentiation to a Neuronal Phenotype.
Julson J, Quinn C, Bownes L, Hutchins S, Stewart J, Aye J J Pediatr Surg. 2023; 58(6):1155-1163.
PMID: 36907773 PMC: 10198809. DOI: 10.1016/j.jpedsurg.2023.02.018.
Gao J, Liang Y, Chen J, Shen H, Liu H Apoptosis. 2023; 28(3-4):639-652.
PMID: 36719470 PMC: 9888343. DOI: 10.1007/s10495-022-01800-6.
To Explore the Stem Cells Homing to GBM: The Rise to the Occasion.
Tsibulnikov S, Drefs N, Timashev P, Ulasov I Biomedicines. 2022; 10(5).
PMID: 35625723 PMC: 9138893. DOI: 10.3390/biomedicines10050986.